NewsRx

Search our medical news database

Ovarian Cancer (Pathophysiology)

Focal Adhesion Kinase Is Overexpressed in Ovarian Carcinoma

Published in Cancer Weekly, November 15th, 1999

by Maryclaire Lindgren -- Focal adhesion kinase is overexpressed in ovarian carcinoma, and thus, may be a possible target for disruption of cancer progression.

"Focal adhesion kinase (FAK) is a cytoplasmic tyrosine kinase that is part of a signaling cascade stimulated by cell adhesion, motility, and growth. This tyrosine kinase, pp125FAK, initially was found to be tyrosine-phosphorylated in response to integrin-mediated cell adhesion, integrin clustering, and cell migration. Subsequently, FAK has been found to be activated by three oncoproteins: v-Sra, v-Crk, and Bar-Abl. Immunofluorescence studies indicate that the pp125FAK protein is...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook